James C. Blair, Director at Clovis Oncology, Inc. (CLVS), sold 36,900 shares at $78.61 ($2.9M) on 2017-08-04, disclosed to the SEC on 2017-08-08.
Open-market sale of $2.9M CLVS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $78.61 | 18,450 | $1.5M | 50.0% |
| 2 | $78.61 | 18,450 | $1.5M | 50.0% |
| Total | $78.61 avg | 36,900 | $2.9M | 100% |
| Filing → |
| BNGO | BUY | 2018-08-27 | $92K | — | Filing → |
| EVOK | SELL | 2016-05-27 | $1.6M | — | Filing → |
| EVOK | SELL | 2016-04-08 | $5K | — | Filing → |